FDA approves Hyqvia to treat primary immunodeficiency

Baxter and Halozyme have received approval from the US Food and Drug Administration (FDA) for Hyqvia to treat adult patients with primary immunodeficiency (PI).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news